Live from the NIH registry
Studies recruiting near Louisville right now
Top 25 of 563 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Baptist Health Louisville — Saint Matthews, Kentucky (6.0 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Myelodysplastic Syndrome, Acute Myeloid Leukemia
Phase 1
Interventional 178 participants sought
Norton Hospitals, Inc — Louisville, Kentucky (8.6 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
University of Louisville — Louisville, Kentucky (8.6 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Baptist Health - Louisville — Louisville, Kentucky (8.6 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
University of Louisville Hospital — Louisville, Kentucky (8.6 mi)
· Sponsor: Hoffmann-La Roche
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer Site in Louisville, KY — Louisville, Kentucky (8.6 mi)
· Sponsor: Mediar Therapeutics
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
University of Louisville Health — Louisville, Kentucky (8.6 mi)
· Sponsor: Lyell Immunopharma, Inc.
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis (AD)
Phase 2
Interventional 105 participants sought
Enveda Investigative Site — Louisville, Kentucky (8.6 mi)
· Sponsor: Enveda Therapeutics
Complex Adult Deformity Surgery (CADS)
Adult Spinal Deformity, Scoliosis
N/A
Observational 1,500 participants sought
Norton Leatherman Spine Center — Louisville, Kentucky (8.6 mi)
· Sponsor: International Spine Study Group Foundation
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
Jewish Hospital — Louisville, Kentucky (8.6 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
Univeristy of Louisville Health — Louisville, Kentucky (8.6 mi)
· Sponsor: GT Medical Technologies, Inc.
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Oropharyngeal Cancer
Phase 3
Interventional 510 participants sought
The James Graham Brown Cancer Center at University of Louisville — Louisville, Kentucky (8.6 mi)
· Sponsor: Canadian Cancer Trials Group
Supporting Resilience Among Re-entered Seniors
Chronic Disease
N/A
Interventional 8 participants sought
New Legacy Reentry — Louisville, Kentucky (8.6 mi)
· Sponsor: University of Louisville
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
Clostridioides Difficile Infection
Phase 2
Interventional 230 participants sought
Research Site — Louisville, Kentucky (8.6 mi)
· Sponsor: AstraZeneca
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
DelRicht Clinical Research - Louisville — Louisville, Kentucky (8.6 mi)
· Sponsor: Ardelyx
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
James Graham Brown Cancer Center ( Site 0058) — Louisville, Kentucky (8.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair
Hand Transplantation, Peripheral Nerve Injuries
N/A
Interventional 180 participants sought
Christine Kleinert Institute for Hand & Microsurgery — Louisville, Kentucky (8.6 mi)
· Sponsor: University of Missouri-Columbia
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
University of Louisville — Louisville, Kentucky (8.6 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Norton Hospital Pavilion and Medical Campus — Louisville, Kentucky (8.6 mi)
· Sponsor: NRG Oncology
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation
Phase 1
Interventional 420 participants sought
University of Kentucky Markey Cancer Center — Louisville, Kentucky (8.6 mi)
· Sponsor: Kura Oncology, Inc.
The Ailliance Post-Market Clinical Study
Spinal Deformity, Spinal Degenerative Disorder
N/A
Interventional 1,000 participants sought
Norton Leatherman Spine Specialists — Louisville, Kentucky (8.6 mi)
· Sponsor: Medtronic Spinal and Biologics
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10086, Louisville, Kentucky — Louisville, Kentucky (8.6 mi)
· Sponsor: Colorado Prevention Center
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Phase 4
Interventional 300 participants sought
Lake Cumberland Rheumatology — New Albany, Indiana (12.6 mi)
· Sponsor: Amgen
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
CommonSpirit Saint Joseph Hospital - Bardstown — Bardstown, Kentucky (26.6 mi)
· Sponsor: NRG Oncology
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
University Medical Center, Inc. ; DBA UofL Health - UofL Hospital/Brown Cancer Center — Louisville, Kentucky (8.6 mi)
· Sponsor: Pfizer